Politics ❯ Government Policy ❯ Healthcare Policy

Drug Pricing Policy

Trump Administration International Relations Consumer Protection Regulatory Actions FDA Regulations Donald Trump Bipartisan Agreements Tariffs and Regulations Most-Favored-Nation Policy Medicare Negotiations Tariff Exemptions Price Controls Executive Orders Mounjaro

Drugmakers to Lift 2026 U.S. List Prices on 350 Branded Medicines

Planned increases reflect list prices that exclude rebates, leaving the effect on out‑of‑pocket costs uncertain.

AstraZeneca Strikes White House Drug-Price Deal, Wins Three-Year Tariff Reprieve

TrumpRx–Pfizer Drug-Price Deal Leaves Key Details Unclear

Pfizer–Trump Drug-Pricing Deal and ‘TrumpRx’ Plan Jolt Health-Care Stocks Higher